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The controversy over Bovine Somatotropin (BST) involves disputes about 
many technical issues: Does milk from cattle treated with BST differ from 
milk now being produced at dairies across the nation? How quickly will 
dairymen adopt BST, and how will it affect economics of scale in dairy 
production? Will dairy production shift from traditional dairy produc-
tion? Will dairy production shift from traditional dairy states to new loca-
tions? How will rural communities be affected? Are we sure that milk pro-
duced by BST-treated cows will be properly metabolized by human con-
sumers? The answers to these and other technical questions are important 
because they bear upon questions of responsibility, social justice and hu-
man (and animal) well-being. There are some applications of these con-
cepts on which our society enjoys a firm consensus, but other applications 
are notoriously contentious.
One fact of post modern society is that decisions by a few individuals to 
develop and disseminate new technologies can have enormous impact 
upon society as a whole. Although there are many instances where these 
impacts are predominantly beneficial, there are few (if any) occasions on 
which they are universally so. Decisions made far from the rural heart-
land, in corporate offices or in research facilities, can effectively determine 
that some producers will have to leave farming, that consumers will be 
buying new food products, and that rural residents, wildlife, and, indeed, 
society as a whole (including future generations) will have to cope with 
pollution or resource depletion. The development of new technologies 
produces new benefits, but it also causes unwanted consequences.
The BST case raises questions about three kinds of unwanted conse-
quences. The first group of impacts are felt by producers who may be 
forced to adopt BST (or to cease production) because of competitive pres-
sures. The second includes consequences for non-human animals. The 
third includes environmental impacts that may bear upon a large number 
of people, extending into future generations. Food safety issues have less 
to do with unwanted impact than with uncertainty.
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Each kind of unwanted consequence is ethically controversial. In most 
sectors of the economy, producers would not expect to be shielded from 
the economic consequences of technical change. Farmers are raising a 
concern more typically voiced by organized labor, as when plant closings 
or new production lines lead to layoffs. Extension of ethical concern to 
farm animals and to environmental impacts are also hotly debated topics. 
Given the assumption that animal husbandry practices carried out for the 
purpose of human food production are generally acceptable, opponents 
of BST must show why this particular technology is cruel or alternatively, 
why traditional standards for animal care should be revised.
Since each of the three points where BST has been linked to unwanted 
outcomes is controversial, it will be useful to look at two ways of framing 
the ethical issues of responsibility.
The Intentional Action Model—Each of three types of unwanted conse-
quence noted above involves impact upon individuals or groups who are 
powerless to avoid being affected. This is clearly the case with respect to 
farm animals and unborn generations of human beings, and it is true to a 
more qualified extent for small scale dairy producers, too.
Bovine somatotropin exists today because a few hundred individuals 
made research and development decisions over a half decade. The deci-
sions and the actions that followed them were undertaken intentionally.
The individuals and groups that carried out research and development 
of BST are capable of actions that impose unwanted consequences upon 
others. The question is whether their possession of this capacity gives 
them an unfair or unjust form of power over these others. Examining BST, 
we find that the companies developing BST have far more economic 
power than do small dairy farmers.
Further, many of the scientists who have participated in the develop-
ment of BST can be thought of as agents for the general public, at least, 
and perhaps for the farm community, in particular. Land-grant universi-
ties, where much of the BST work has been done, have historically ac-
cepted a further mandate to do science that will strengthen the develop-
ment of rural communities. As such, dairy farmers may have a special 
claim upon these institutions. Although no one has argued that scientists 
have a special responsibility to look out for animals, it is not uncommon 
or unreasonable to think that the scientific community is well placed to 
look out for the general public’s interests in environmental quality.
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The fact that BST emerges as a technology for which these consider-
ations are relevant does not settle the issue in favor of BST’s critics. At most 
they establish a burden of proof in favor of the farm, animals and environ-
mental interests that bear the costs of unwanted technical change. One 
might interpret the political debate that has raged over BST as a working 
out of just such an exchange of views in the democratic political process. 
The Consequence Evaluation Model—The idea that any technical change 
produces winners and losers invites us to think of any new technology as a 
social bargain in which there are both costs and benefits. The key to evalu-
ating this social bargain lies in identifying and measuring the full range of 
costs and benefits. While one should not underestimate the difficulty of 
making these judgements, the idea that a technology’s costs and benefits 
can be compared with the costs and benefits of no technology provides an 
attractive way of discharging the imperative of responsibility for technical 
change.
When applied to BST, the consequence evaluation model would regard 
adverse, unwanted outcomes as costs that should be weighed against the 
projected benefits derived from lower milk costs. When one adopts a con-
sequence evaluation model for assessing new technologies, the question of 
whether BST is an ethically acceptable technology hangs upon the answers 
to these technical questions.
When one compares total outcomes from two or more options (at a 
minimum, the options include BST and no BST) there is no obvious rea-
son why intentional action should enter the picture at all. There are costs 
and benefits associated with the status quo. The possibility of taking very 
different approaches to the problem of unwanted outcomes earn itself feed 
policy controversy. It is far easier for two who have different interpretations of 
responsibility to talk past each other than it is for them to communicate.
ETHICS AND UNCERTAINTY
By its very nature, technical change involves unprecedented events. The 
reality of disagreement among alleged experts creates a situation in which 
a member of the lay public, lacking even the evidence to make informed 
judgements about who to believe, quite reasonably comes to regard all 
claims about the likely consequences of technical change with justifiable 
skepticism.
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The unfortunate upshot is that political decisions about technology often 
become dominated by uncertainty. Technical uncertainty creates an op-
portunity for experts to disagree. When experts disagree, non-experts are 
faced with uncertainty about who to believe.
The ethical character of the BST debate changed drastically when 
claims about the safety of consuming milk from cows treated with BST be-
came contested. Prior to the time that doubts about the safety of milk were 
raised, the issue was one of how to resolve issues of responsibility for the 
unwanted consequences of introducing BST. With the advent of contro-
versy over food safety, the potential spectrum of affected parties increased 
dramatically.
What is even more important is the way that the ethical issue shifted 
from being one of dealing with unwanted consequences to one of uncer-
tainty. There has never been serious scientific evidence to suggest that 
there would be unwanted health consequences for consumers of BST 
milk. Consumer groups reacting to the food safety issue were not reacting 
to a health risk per se. Consumer groups were reacting to uncertainty, to a 
problem in deciding who to believe about BST and milk.
In understanding the way that ethics bear upon risk and uncertainty, it 
is crucial to see that the consumer’s information about the safety of BST is 
all subject to a conditional probability that the source of that information 
is either ignorant or, worse, willing to deceive them. Many technical au-
thors have taken to describing the difference between risks calculated on 
the basis of scientific evidence and risks calculated on the basis of corrigi- 
bility of human beings who report scientific findings as a distinction be-
tween “real” and “perceived” risk. This choice of words is sometimes un-
fortunate, for it can be taken to imply that the lay person is responding to 
extraneous and irrelevant evidence.
Given the background of the uncertainty problem faced by food con-
sumers and consumer advocates, it is not surprising that the issue evolved 
into a debate about the risks of BST and milk. The scientific community 
has come to view risk issues as an expected value problem, and this is the 
way that the food safety issue for BST has been approached. While there 
are clearly many cases in which the assessment of expected values is the 
right approach to take for food safety, neglect of alternatives, burden-of- 
proof approaches may have been a better choice for BST.
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Responding to uncertainty problems with technical risk assessments is, 
to a person unschooled in probability and consequence evaluation, little 
more than saying, “Trust me "Uncertainty issues are politically fractious 
and intense. It is far from clear that burden of proof approaches would 
have fared better. It is possible, however, that an agreement to label BST 
milk might have been interpreted as a gesture of good faith, one that em-
powers consumers to judge the risks of BST and milk for themselves.
While labels satisfy a burden of proof for acceptable risk, requiring labels 
may have policy implications that are themselves unacceptable.
Democratic political theory has evolved around the concept of a social 
contract. BST has tested that social contract. Researchers and private 
companies have undertaken research and development on BST with the 
expectation that, if the product finds market acceptance, their efforts will 
be rewarded. While it is reasonable that they should have expected to deal 
with some of the unwanted consequences of BST, it was not reasonable to 
expect that food safety issues would be among them. The emergence of 
uncertainty and, in turn, the food safety issue is evidence of trouble in the 
contract. It is evidence of a lack of confidence in science and in science in-
stitutions. This is a development that should be viewed as quite serious, 
not only for science, but for the foundations of democratic institutions. 
The problem is that both commerce and political decision-making require 
a certain amount of trust. Whatever the causes, and however just or unjust 
the suspicion of science might be, the largest and most serious ethical is-
sue associated with BST is the matter of trust. All the other ethical ques-
tions feed into this one.
One way of solving this problem is to build a high wall between that 
component of science which is in a position of public trust, and that por-
tion of science which is involved in the development of technologies that 
may produce unwanted consequences. Public science, conducted at non-
profit institutions, would enjoy public confidence. Private science, con-
ducted in the private sector, would be held to the same degree of account-
ability normally expected of commercial activity. The flaws in this solu-
tion are complicated and subtle. Features of contemporary science that 
make this ideal very difficult to achieve include:
1- Scientific research does not respect the public/private divide.
2- Enforcing a strong separation between public and private science is im-
practical.
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3-Public science institutions are finding it necessary to cultivate private 
sources of research funding.
4~A strong separation between public and private science sectors might 
well weaken public science.
Therefore the dilemma is deep. The tension between the regulatory and 
the technology stimulating roles of science erodes public trust in science 
institutions. At the same time, any solution to this problem must be sensi-
tive to the delicate network of personal relationships that makes science 
possible.
CONCLUSION
The ethical controversy over BST arose because, like many technologies, it 
may produce some effects that are unwanted. There is no reason to think 
that the unwanted consequences of BST are particularly dramatic or ex-
treme, but the fact that decision makers within public research organiza-
tions or private companies can affect others makes these unwanted out-
comes an issue of some significance. The importance is increased, how-
ever, because of the food safety questions that have been raised, and be-
cause of the climate of uncertainty that they generated. It is the uncer-
tainty issue that truly threatens to keep BST off the market at this writing, 
and which the developers of the technology had no reason to expect. This, 
in turn leads to the question of trust that is crucial to democratic institu-
tions. This is not to say that the success or failure of U.S. constitutional de-
mocracy hangs upon the BST decision, but it is to say that this policy 
problem is an example of a problem that can be expected to recur in the 
future.
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